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It is well known that glucocorticoids can affect the concentration  of leukocytes in 
peripheral blood as well as the integrity of lymphoid tissues (1,  2).  Less well known, 
however, is their influence on the bone marrow and, particularly, the degree to which 
these hormones contribute to the modulation of hematopoiesis in normal and disease 
states. Cortisone in high, nonphysiologic dosage was found by Cardinali et al. (3)  to 
depress  mitotic  activity  of  erythroid  and  myeloid  components  of  hamster  bone 
marrow. Metcalf (4) observed that high doses of cortisone also decreased the number 
of presumptive granulopoietic  stem cells  (CFU-C) 1 in  mouse bone marrow in  vitro 
and in vivo and decreased the concentration of colony-stimulating activity (CSA) in 
mouse serum.  A  depression of CFU-C was also reported  in mouse marrow cultures 
treated with dexamethasone (5). The effects of glucocorticoids on committed erythroid 
stem  cells  are  less  well  characterized,  however.  Singer  et  al.  (6)  noted  a  marked 
inhibitory effect of eortisol on a  class of erythroid progenitors  (CFU-E)  in rat  bone 
marrow, whereas Golde et al. (7) found a definite stimulatory effect of dexamethasone 
on CFU-E in mouse fetal liver cultures and a slight stimulatory effect in adult mouse 
marrow cultures.  Results of in vivo studies also differ on the effect of glucocorticoids 
on  erythropoiesis.  According  to  Malgor  et  al.  (8),  dexamethasone  increased  the 
erythroid component of bone marrow. Because nephrectomy and anti-erythropoietin 
antibody abolished  the response, increased production  of erythropoietin was impli- 
cated  as  the  mediator.  On  the  other  hand,  Gordon  et  al.  (9)  have  shown  that 
prednisolone did not affect erythropoiesis in normal adult mice and that high doses 
of prednisolone were, in fact, inhibitory. 
To gain further insight into the possible role of glucocorticoids in the regulation of 
hematopoiesis, we studied  dose-response relationships with dexamethasone and cor- 
tisone, focusing on both the very early erythroid progenitors  (BFU-E)  and CFU-C. 
Our data reveal that BFU-E are much more sensitive than CFU-C to inhibition by 
low doses of dexamethasone or cortisone. 
Materials and Methods 
Mice.  Adult  female CF1  mice  (Charles  River Breeding  Laboratories, Inc., Wilmington, 
Mass.) were used in all experiments. 
* Supported by the U. S. Department of Energy. 
l Abbreviations  used  in  this paper:  BFU-E, early  committed erythroid  progenitor;  CFU-C, committed 
granulopoietic progenitor; CFU-E, late committed erythroid progenitor; CSA, colony-stimulating activity. 
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TABLE  I 




Colonies per 4  ×  l0  b bone marrow cells (mean ±  SE) 
BFU-E  BFU-E  CFU-C 
nM  8 days  14 days  8 days 
0  35.2  ±  6.1(4)  61.8  +  13.9 (4)  127 ±  6.6 (4) 
0.2  33.0  +  5,8  58.4  -  7.2 
0.6  27.6  ±  2.6  40.4  ±  2.2* 
2.0  23.6  ±  2.6*  27.7  +  2.8*  116 +  6.5 
2.0  24.3  ±  1.8"  44.5  +  6.7*  110 ±  6.7 
2.0  20,1  ±  1.9"  41.4  ±  4,3*  126 ±  7.4 
5.0  10.5 ±  1.0"  31.3  ±  2.4* 
20  4.6 ±  1.5'  10.5 ±  1.2"  95.2  ±  6.6* 
20  2.6  ±  1.1"  4,9 ±  2.4*  80.3  ±  5.7* 
20  86.5  ±  11,3" 
200  4.2  ±  1.5"  6.3  ±  1.7" 
200  3.5  ±  1.0"  6.2  ±  0.7*  53.8  ±  5,1" 
200  0.9 ±  1.0"  1.2 ±  3.6*  19.1 ±  3.8" 
800  30.0  +  3.3* 
* Significantly different from control values (P <  0.05). 
Cell Culture.  Bone marrow cells were flushed from femurs with  1.0 ml of Hanks' balanced 
salt solution  (Grand Island Biological Co., Grand Island, N. Y.).  A  single cell suspension was 
made by passage through a  25-gauge needle; cells were counted on a hemocytometer. The bone 
marrow  was  cultured  with  alpha  medium  supplemented  with  10%  fetal  calf serum  (Grand 
Island  Biological  Co.),  10%  horse serum  (Flow  Laboratories,  Inc.,  Rockville,  Md.)  and  10% 
trypticase  soy  broth  (Grand  Island  Biological  Co.),  and  10  -4  M  2-mercaptoethanol  in  1% 
methyl cellulose (10-12). Quadruple cultures containing 4  ×  105 cells each were incubated at 
37°C in an atmosphere of 100% relative humidity and 5.5% CO2. Assays for CFU-C and BFU- 
E  were  carried  out  simultaneously  on  the same  bone  marrow  sample.  Cultures  for  BFU-E 
contained 5  IU of erythropoietin (Step III Connaught).  Cultures  for CFU-C  contained  1/16 
maximal concentration of CSA prepared from L-cell conditioned medium (13). After 8 days of 
incubation colonies containing 50 or more cells were scored with a  dissecting microscope at a 
magnification  of  ×  40.  They  were  returned  to  the  incubator and  scored  again  at  14  days. 
Verification  of  erythroid  bursts  was  determined  with  0.2%  tetramethyl  benzidine  (Sigma 
Chemical Co., St.  Louis, Mo.)  in  10% acetic acid and 0.12% H202 applied directly to cultures 
(14).  Hemoglobin-containing colonies stained  fully  after 3  min,  whereas  peroxidase-positive 
granulocytic colonies stained after 10 min. 
Dexamethasone  (Sigma Chemical  Co.)  was dissolved  in  100% ethanol and diluted  1/104- 
7  1/10  with distilled water. The exact concentration was determined spectrophotometrically by 
4  1  1  measuring absorption at 250 nm and assuming ~  =  1.4  ×  10  M- cm-  (15). 50 #1 of solution 
was added  to each culture.  As a  control for the effects of ethanol, the same volume of 1/104 
dilution of ethanol was added to the plates not containing dexamethasone. Cortisone (Sigma 
Chemical Co.)  was dissolved in  100% ethanol and diluted  1/103-1/105 before addition of 50 
/11 to each culture. The final vol of all cultures was  1.15 ml. 
In  a  separate  experiment  bone  marrow  was  incubated  in  Hanks'  balanced  salt  solution 
containing various concentrations of dexamethasone for 1 h  before plating. 
Statistical  Analysis.  Individual colony counts were normalized to the mean of control data 
from four replicate experiments. Differences between means were analyzed with Student's two- 
tailed t test. 
Results 
The results of individual and replicate studies of BFU-E and CFU-C sensitivity to 
dexamethasone revealed that the erythropoietic progenitors were considerably more 
sensitive  than  the  granulopoietic  (Table  I).  The  overall  pattern  of  the  log  dose- FRANKLIN  ZALMAN,  MARY  A.  MALONEY,  AND  HARVEY  M.  PATT 
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F[o.  I.  BFU-E and CFU-C as a function of dexamethasone concentration  in the culture medium. 
(Percent  colonies,  mean of two  to three experiments  +  SE.)  Differences  between  percent  BFU-E 
and percent CFU-C were significant  at all concentrations of dexamethasone  (P <  0.01) except 0.2 
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Fta.  2.  Effect  of dexamethasone treatment before and during bone marrow culturing. (Percent 
colonies ±  SE.) Differences between percent BFU-E and percent CFU-C were significant at 2 nM 
and 20 nM (P< 0.0025)  and at 200 nM (P <  0.01). I~, BFU-E, 8 days; g, BFU-E, 14 days; [], CFU- 
C, 8 days. 
response relationship  was sigmoidal, with an apparent  threshold  for BFU-E at  =  2 
×  10 -1°  M  dexamethasone  and  a  linear  component  (slope  --  -40,  correlation 
coefficient  -- 0.95, P <  0.01) that became asymptotic at about 90% BFU-E inhibition 
with  concentrations  of dexamethasone  above 2  X  10  -s M.  As shown  in Fig.  1, the 
dose-response  relationship  for CFU-C  was  similar.  Although  the  linear  component 
(slope  --- -30, correlation coefficient  =  0.95, P <  0.01) was not significantly different 
from that found for BFU-E, the curve was shifted to the right by at least an order of 
magnitude along the dose axis, the dexamethasone concentration for 50% inhibition 
being 60  X  10  -9 M  for CFU-C compared to 3  x  10 -9 M  for BFU-E.  The BFU-E 
response to dexamethasone was similar for the 8- and  14-day colony counts. 
When bone marrow was treated with dexamethasone  for 1 h  before plating,  with 
continued  exposure  to the  glucocorticoid after  plating,  the  inhibitory  response  was 
increased  for  both  BFU-E  and  CFU-C,  but  their  differential  sensitivity  was  not 
affected (Fig. 2). 
The  effect  of cortisone  was  generally  similar  to  that  of dexamethasone  (Fig.  3); 70  EFFECTS  OF GLUCOCORTICOIDS ON  HEMOPOIETIC  PROGENITORS 
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Fxo. 3.  BFU-E  and CFU-C  as a function  of cortisone concentration  in the culture medium. 
(Percent colonies +  SE.) Differences  between percent BFU-E and percent CFU-C were significant 
at all concentrations of cortisone (P < 0.0025). O, BFU-E, 8 days; A, BFU-E, 14 days; O, CFU-C, 
8 days. 
BFU-E was inhibited 60% by 0.1  #g/ml. The contrast between the BFU-E and CFU- 
C  responses to cortisone was even more striking than that seen with dexamethasone. 
There was little CFU-C inhibition  with low doses of cortisone, the maximum being 
about  18% at  1 #g/ml. 
Discussion 
In many tissues, the catabolic action of glucocorticoids results in decreased synthesis 
and  increased  degradation  of protein,  RNA,  and  DNA.  Glucocorticoids  are  also 
known to inhibit amino acid and glucose uptake. Although the inhibition of BFU-E 
and CFU-(] activity described here may merely reflect the general catabolic effect of 
this class of hormones, the large difference in sensitivity between BFU-E and CFU-C 
indicates  that  the  inhibition  by  glucocorticoids  was  specific  rather  than  general. 
Although  we observed less CFU-C inhibition  at lower doses of glucocorticoids than 
reported previously (5), our systems were sufficiently different particularly in source 
and concentration  of CSA to preclude direct comparison;  it is  known  that  CFU-C 
consist of subpopulations that respond selectively to CSA of diverse origin (16, 17). By 
using a fairly low CSA concentration, we may have selected for a sensitive population 
of CFU-C. This is perhaps a  more realistic physiologic condition than that obtained 
with maximal stimulation at high CSA concentration. CFU-C that are more difficult 
to  trigger  and  require  a  higher  concentration  of CSA  may also  be more prone  to 
being turned off. The CFU-C response we observed with cortisone agrees closely with 
that seen by Metcalf (4) at a similar concentration. 
The basis of the large differential glucocorticoid sensitivity of BFU-E and CFU-C 
is  not  known.  It  may  reflect  differences  in  the  number  of receptors  available  for 
interaction with glucocorticoids or differences in the consequences of their binding by 
glucocorticoids. Despite the relative insensitivity of CFU-C, their macrophage progeny 
are  quite  sensitive,  the  specific  binding  of  glucocorticoids  being  correlated  with 
decreased secretion of elastases and other enzymes (18). It is possible that differences 
in heterogeneity of the cell population  may also be a  factor. In contrast to CFU-C, 
which  are  presumed  to  have  a  broad  age  distribution,  BFU-E  are  considered  to 
constitute only very early progenitors and may be representative of a  more homoge- 
neous committed stem cell population. 
BFU-E are thought to generate a pool of more differentiated erythroid progenitors 
known as CFU-E; dexamethasone has been reported to increase the number of CFU- FRANKLIN ZALMAN, MARY A.  MALONEY, AND HARVEY M.  PATT  71 
E in adult mouse bone marrow by 36 :t:  24% (7). Because of the considerable standard 
error, this increase is of questionable significance. In several experiments, we observed 
a  similar but statistically insignificant increase in CFU-E with dexamethasone treat- 
ment. If an increase in CFU-E indeed occurs, the effect of glucocorticoids on the late 
erythroid precursor pool would  tend to counteract  the effect on the early erythroid 
pool.  Differential  control  of precursor  pools  in  series  would  provide  an  efficient 
mechanism for dampening the effect of glucocorticoids and perhaps for fine tuning of 
the size of the erythron. 
Our findings suggest that the size of the granulocyte-macrophage progenitor pool 
is relatively unaffected by physiologic concentrations and fluctuations of glucoeorti- 
colds. Because of the rapid turnover of the vital granulocytic elements in peripheral 
blood, this is of more than passing interest. On the other hand, whatever the reason 
behind the effect, transient changes in proliferation of committed erythroid stem cells 
due to physiologic fluctuations of glucocorticoid concentration would have a negligible 
impact because of the much slower turnover of circulating erythrocytes. 
Summary 
The sensitivity of erythropoietic (BFU-E) and granulopoietie  (CFU-C) progenitor 
cells to dexamethasone and cortisone was studied in cultures of mouse bone marrow. 
Although  the  log dose-response relationships  had  a  similar form, the  BFU-E were 
much more sensitive than  the CFU-C  to either glucocorticoid. The dexamethasone 
concentration  for 50% inhibition was 3  X  10  -s M  for BFU-E and 60  X  10  -9 M  for 
CFU-C. The differential sensitivity to cortisone was even greater, with 60% inhibition 
of BFU-E  and  18%  inhibition  of CFU-C  at  0.1  #g/ml.  These  findings  suggest  a 
specific rather than a  general response to glucocorticoids and indicate that granulo- 
cyte-macrophage progenitors  are  less  affected  than  early erythroid  progenitors  by 
physiologic concentrations of these hormones. 
We wish to acknowledge the helpful discussions with Leora Shaltiel Zalman. 
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